用于前列腺癌的可生物降解聚合物促黄体生成素释放激素类似物：一种新型肽递送系统的应用 - Suppr

Suppr

超能文献

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.

作者信息

Williams G, Kerle D, Griffin S, Dunlop H, Bloom S R

出版信息

Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1580-1. doi: 10.1136/bmj.289.6458.1580.

DOI:10.1136/bmj.289.6458.1580

PMID:6239674

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1443905/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e9/1443905/b6010d999f9d/bmjcred00531-0027-a.jpg

相似文献

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.用于前列腺癌的可生物降解聚合物促黄体生成素释放激素类似物：一种新型肽递送系统的应用

Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1580-1. doi: 10.1136/bmj.289.6458.1580.

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.长期使用促黄体生成素释放激素治疗前列腺癌未能抑制血清促黄体生成素和睾酮。

Br Med J (Clin Res Ed). 1984 Sep 29;289(6448):831. doi: 10.1136/bmj.289.6448.831-b.

An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.

Eur J Surg Oncol. 1985 Jun;11(2):159-65.

Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.促黄体生成素释放激素类似物ICI 118630（诺雷德）长效制剂用于前列腺癌患者的初步报告。

Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):185-7. doi: 10.1136/bmj.290.6463.185.

Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.

J Urol. 1988 Oct;140(4):775-7. doi: 10.1016/s0022-5347(17)41809-x.

Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.通过每月注射一次长效促性腺激素释放激素类似物进行前列腺癌治疗。

Acta Oncol. 1988;27(4):361-4. doi: 10.3109/02841868809093555.

Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.

Br J Urol. 1988 Oct;62(4):352-4. doi: 10.1111/j.1464-410x.1988.tb04364.x.

Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).使用缓释长效促性腺激素释放激素类似物（诺雷德长效注射剂）治疗晚期前列腺癌。

Scand J Urol Nephrol Suppl. 1988;110:109-12.

Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.

Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1407-8. doi: 10.1136/bmj.293.6559.1407-a.

Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.诺雷德：一种用于治疗晚期前列腺癌的长效、每月一次的促黄体生成素释放激素类似物。

J Clin Oncol. 1987 Jun;5(6):912-7. doi: 10.1200/JCO.1987.5.6.912.

引用本文的文献

Endocrine treatment of prostatic cancer.前列腺癌的内分泌治疗

J R Soc Med. 1985 Oct;78(10):797-9. doi: 10.1177/014107688507801001.

The first clinical use of depot buserelin for advanced prostatic carcinoma.

Cancer Chemother Pharmacol. 1986;18(2):174-5. doi: 10.1007/BF00262291.

Gonadotrophin hormone releasing analogues open new doors in cancer treatment.促性腺激素释放类似物为癌症治疗打开了新的大门。

Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1084-5. doi: 10.1136/bmj.295.6606.1084.

A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer.

Cancer Chemother Pharmacol. 1989;25(3):219-20. doi: 10.1007/BF00689587.

本文引用的文献

Desmopressin response of enuretic children. Effects of age and frequency of enuresis.

Am J Dis Child. 1983 Oct;137(10):962-3. doi: 10.1001/archpedi.1983.02140360026009.

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):468-9. doi: 10.1136/bmj.289.6443.468.

Prostatic cancer: treatment with long-acting LHRH analogue.

Br J Urol. 1983 Dec;55(6):743-6. doi: 10.1111/j.1464-410x.1983.tb03417.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验